Vimarsana
Biggest News Aggregation in the World

Page 2 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

DURECT Co. (NASDAQ:DRRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - Vimarsana News

DURECT Co. (NASDAQ:DRRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the five analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price […]

Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews.com - Vimarsana News

Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Down 0.1 % Shares of PIRS stock opened at $10.48 on Thursday. Pieris Pharmaceuticals has a twelve month low of $10.31 and […]

Pan American Silver (NYSE:PAAS) PT Raised to $23.00 at Scotiabank - Vimarsana News

Pan American Silver (NYSE:PAAS) PT Raised to $23.00 at Scotiabank

Pan American Silver (NYSE:PAAS – Free Report) (TSE:PAAS) had its price target hoisted by Scotiabank from $20.00 to $23.00 in a research note issued to investors on Thursday morning, Benzinga reports. Scotiabank currently has a sector outperform rating on the basic materials company’s stock. Other equities research analysts have also issued reports about the stock. […]

StockNews.com Begins Coverage on Pieris Pharmaceuticals (NASDAQ:PIRS) - Vimarsana News

StockNews.com Begins Coverage on Pieris Pharmaceuticals (NASDAQ:PIRS)

StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Down 0.1 % NASDAQ PIRS opened at $10.48 on Thursday. The business’s 50-day moving average price is $12.87 and […]

Pieris Pharmaceuticals (NASDAQ:PIRS) Coverage Initiated at StockNews.com - Vimarsana News

Pieris Pharmaceuticals (NASDAQ:PIRS) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance PIRS stock opened at $10.48 on Thursday. The firm has a market cap of $13.83 million, a price-to-earnings ratio of […]